In a filing, Artivion Inc revealed its Officer AMY HORTON acquired Company’s shares for reported $0.31 million on Aug 08 ’25. In the deal valued at $38.49 per share,7,992 shares were bought.
Then, Stanton Marshall S. sold 15,000 shares, generating $442,500 in total proceeds. Upon selling the shares at $29.50, the SVP, Clinical & MD Affair now owns 64,200 shares.
Before that, MARSHALL STANTON bought 15,000 shares. Artivion Inc shares valued at $442,500 were divested by the Officer at a price of $29.50 per share.
Canaccord Genuity initiated its Artivion Inc [AORT] rating to a Buy in a research note published on June 17, 2025; the price target was $35. A number of analysts have revised their coverage, including JMP Securities’s analysts, who began to cover the stock in late October with a ‘”a Mkt outperform”‘ rating. Lake Street also remained covering AORT and reiterated its “Buy” recommendation on September 27, 2022. Lake Street started covering the stock on August 08, 2022. It rated AORT as “a Buy”.
Price Performance Review of AORT
On Friday, Artivion Inc [NYSE:AORT] saw its stock jump 25.23% to $40.95. Over the last five days, the stock has gained 32.44%. Artivion Inc shares have risen nearly 61.22% since the year began. Nevertheless, the stocks have risen 43.23% over the past one year.
How much short interest is there in Artivion Inc?
A steep rise in short interest was recorded in Artivion Inc stocks on 2025-07-15, dropping by -0.16 million shares to a total of 1.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 1.52 million shares. There was a decline of -11.96%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 03, 2022 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $30 price target.
